ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
129.480,89
0,21%
S&P 500
5.187,67
0,00%
US Dollar vs BRL
5,0892
0,00%
Bitcoin
61.634,80
0,73%
Brent Oil
83,73
0,20%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. AMEX
  6. Pharmathene, (delisted) (PIP)

  7. Pharmathene, (delisted) (PIP) Notícias

PIP

Pharmathene, (delisted) (PIP)

Pharmathene, (delisted)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:AMEX:PIP
DataHoraFonteTítuloCódigoCompanhia
01/09/201709:49Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:PIPPharmathene, (delisted)
01/09/201709:47Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:PIPPharmathene, (delisted)
28/08/201717:57Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:PIPPharmathene, (delisted)
23/08/201717:29Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:PIPPharmathene, (delisted)
22/08/201717:50Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:PIPPharmathene, (delisted)
21/08/201718:02Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)AMEX:PIPPharmathene, (delisted)
21/08/201717:10Edgar (US Regulatory)Current Report Filing (8-k)AMEX:PIPPharmathene, (delisted)
18/08/201718:18Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)AMEX:PIPPharmathene, (delisted)
14/08/201707:08Edgar (US Regulatory)Quarterly Report (10-q)AMEX:PIPPharmathene, (delisted)
10/08/201710:59Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)AMEX:PIPPharmathene, (delisted)
20/07/201718:02Edgar (US Regulatory)Amended Current Report Filing (8-k/a)AMEX:PIPPharmathene, (delisted)
15/05/201718:22Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:PIPPharmathene, (delisted)
15/05/201718:17Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)AMEX:PIPPharmathene, (delisted)
15/05/201718:06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:PIPPharmathene, (delisted)
10/05/201717:13Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)AMEX:PIPPharmathene, (delisted)
05/05/201714:48Edgar (US Regulatory)(25)AMEX:PIPPharmathene, (delisted)
04/05/201718:18Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)AMEX:PIPPharmathene, (delisted)
03/05/201717:57Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)AMEX:PIPPharmathene, (delisted)
03/05/201717:30PR Newswire (US)PharmAthene Reports First Quarter 2017 Financial and Operational ResultsAMEX:PIPPharmathene, (delisted)
07/04/201707:01Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:PIPPharmathene, (delisted)
03/04/201717:06Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:PIPPharmathene, (delisted)
31/03/201715:41Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)AMEX:PIPPharmathene, (delisted)
14/03/201717:45Edgar (US Regulatory)Annual Report (10-k)AMEX:PIPPharmathene, (delisted)
14/03/201717:03PR Newswire (US)PharmAthene Reports Year-End 2016 Financial and Operational ResultsAMEX:PIPPharmathene, (delisted)
13/03/201709:03PR Newswire (US)PharmAthene Announces Record Date and Meeting Date for Special Meeting of Stockholders Regarding Proposed Merger Transaction ...AMEX:PIPPharmathene, (delisted)
08/02/201711:29InvestorsHub NewsWirePPMH Wholly-Owned Subsidiary, mPath Discovery LLC, Expands Client Base with Multiple New Channel Partnership AgreementsAMEX:PIPPharmathene, (delisted)
06/02/201709:33PR Newswire (US)Altimmune to Present at the BIO CEO & Investor ConferenceAMEX:PIPPharmathene, (delisted)
03/02/201720:27Edgar (US Regulatory)Securities Registration: Business Combination (s-4)AMEX:PIPPharmathene, (delisted)
19/01/201709:30PR Newswire (US)PharmAthene and Altimmune Announce Merger to Create Immunotherapeutics Company Targeting Infectious DiseasesAMEX:PIPPharmathene, (delisted)
22/11/201620:08Edgar (US Regulatory)Amended Quarterly Report (10-q/a)AMEX:PIPPharmathene, (delisted)
 Apresentando as notícias mais relevantes sobre:AMEX:PIP

Seu Histórico Recente

BOV
COGN3
COGNA ON
BOV
IBOV
Índice Bovespa
BOV
VVEO3
CM Hospitalar ON
BOV
JHSF3
JHSF PART ON
BOV
OIBR3
OI ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
SGPS3
SPRINGS ON
BOV
ENAT3
ENAUTA ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
BRKM5
BRASKEM PNA
BOV
HBRE3
HBR Realty Empreendiment... ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados